We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+3.23%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$906M
AUM Growth
+$185M
(+26%)
Cap. Flow
+$147M
Cap. Flow
% of AUM
16.23%
Top 10 Holdings %
Top 10 Hldgs %
24.88%
Holding
586
New
69
Increased
148
Reduced
238
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Delta Air Lines
DAL
|
+$23.1M |
| 2 |
WEC Energy
WEC
|
+$22.9M |
| 3 |
PACCAR
PCAR
|
+$22.2M |
| 4 |
Public Service Enterprise Group
PEG
|
+$22.1M |
| 5 |
JB Hunt Transport Services
JBHT
|
+$21.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$23.7M |
| 2 |
Deutsche Bank
DB
|
+$15.9M |
| 3 |
UnitedHealth
UNH
|
+$14.4M |
| 4 |
Cencora
COR
|
+$13.9M |
| 5 |
OCR
OMNICARE INC
OCR
|
+$13.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 25.97% |
| 2 | Industrials | 17.33% |
| 3 | Consumer Discretionary | 11.57% |
| 4 | Healthcare | 7.92% |
| 5 | Utilities | 7.88% |
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q1 2015 Portfolio in Review
As of Q1 2015, Exane Derivatives held 586 positions worth $906M, up 26% from $721M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Exane Derivatives deployed $147M of net new capital in Q1 2015, opening 69 new positions and adding to 148 existing holdings. Its largest new stake was WEC Energy: 438,756 shares worth $21.7M.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 30% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $23.7M trimmed.
- Exane Derivatives's largest Q1 2015 buy was WEC Energy: 438,756 shares worth $21.7M.
- Exane Derivatives added most to Delta Air Lines in Q1 2015, an estimated $23.1M increase.
- Exane Derivatives's biggest Q1 2015 reduction was Vertex Pharmaceuticals, cutting an estimated $23.7M.
- Exane Derivatives fully exited O'Reilly Automotive in Q1 2015, selling an estimated $13.3M.
- Exane Derivatives's ten largest holdings make up 25% of its $906M portfolio in Q1 2015.
- Exane Derivatives opened 69 new positions and closed 71 in Q1 2015.
- Exane Derivatives's portfolio value rose 26% quarter-over-quarter to $906M.
Based on Exane Derivatives's 13F filing for Q1 2015, filed 15 May 2015.